Rns15 Dec 2020 08:05
Sensyne have launched their first product in the US to help those who are affected by diabetes during pregnancy.
Sensyne is concluding a pilot of GDm-Health at Jefferson Health, one of the fastest growing health systems in the U.S., comprising 14 hospitals with 2,800 beds, 6,000 physicians and 7,000 nursing staff with 18,000 births a year. Results from the pilot are expected to be reported in a peer-reviewed journal in early 2021.
Should see a nice rise today